Pal D - Search Results

1

A comprehensive insight on ocular pharmacokinetics.

Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, Hadji H, Mitra R, Pal D, Mitra AK. Agrahari V, et al. Among authors: pal d. Drug Deliv Transl Res. 2016 Dec;6(6):735-754. doi: 10.1007/s13346-016-0339-2. Drug Deliv Transl Res. 2016. PMID: 27798766 Free PMC article. Review.

2

Role of membrane transporters and metabolizing enzymes in ocular drug delivery.

Vadlapatla RK, Vadlapudi AD, Pal D, Mitra AK. Vadlapatla RK, et al. Among authors: pal d. Curr Drug Metab. 2014;15(7):680-93. doi: 10.2174/1389200215666140926152459. Curr Drug Metab. 2014. PMID: 25255873 Review.

3

Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.

Yang X, Shah SJ, Wang Z, Agrahari V, Pal D, Mitra AK. Yang X, et al. Among authors: pal d. Drug Deliv. 2016 Sep;23(7):2399-2409. doi: 10.3109/10717544.2014.996833. Epub 2015 Jan 7. Drug Deliv. 2016. PMID: 25564964

4

Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.

Yang X, Sheng Y, Ray A, Shah SJ, Trinh HM, Pal D, Mitra AK. Yang X, et al. Among authors: pal d. Drug Deliv. 2016 Sep;23(7):2532-2540. doi: 10.3109/10717544.2015.1023384. Epub 2015 Mar 16. Drug Deliv. 2016. PMID: 25775276

5

Transporter effects on cell permeability in drug delivery.

Mandal A, Agrahari V, Khurana V, Pal D, Mitra AK. Mandal A, et al. Among authors: pal d. Expert Opin Drug Deliv. 2017 Mar;14(3):385-401. doi: 10.1080/17425247.2016.1214565. Epub 2016 Aug 5. Expert Opin Drug Deliv. 2017. PMID: 27449574 Review.

6

Recent perspectives on the delivery of biologics to back of the eye.

Joseph M, Trinh HM, Cholkar K, Pal D, Mitra AK. Joseph M, et al. Among authors: pal d. Expert Opin Drug Deliv. 2017 May;14(5):631-645. doi: 10.1080/17425247.2016.1227783. Epub 2016 Sep 6. Expert Opin Drug Deliv. 2017. PMID: 27573097 Free PMC article. Review.

7

How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.

Agrahari V, Agrahari V, Mandal A, Pal D, Mitra AK. Agrahari V, et al. Among authors: pal d. Expert Opin Drug Deliv. 2017 Oct;14(10):1145-1162. doi: 10.1080/17425247.2017.1272569. Epub 2016 Dec 28. Expert Opin Drug Deliv. 2017. PMID: 27967247 Review.

8

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Mandal A, Pal D, Agrahari V, Trinh HM, Joseph M, Mitra AK. Mandal A, et al. Among authors: pal d. Adv Drug Deliv Rev. 2018 Feb 15;126:67-95. doi: 10.1016/j.addr.2018.01.008. Epub 2018 Jan 13. Adv Drug Deliv Rev. 2018. PMID: 29339145 Free PMC article. Review.

9

Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease.

Mandal A, Gote V, Pal D, Ogundele A, Mitra AK. Mandal A, et al. Among authors: pal d. Pharm Res. 2019 Jan 7;36(2):36. doi: 10.1007/s11095-018-2556-5. Pharm Res. 2019. PMID: 30617777 Review.

10

Identification and functional characterization of riboflavin transporter in human-derived retinoblastoma cell line (Y-79): mechanisms of cellular uptake and translocation.

Kansara V, Pal D, Jain R, Mitra AK. Kansara V, et al. Among authors: pal d. J Ocul Pharmacol Ther. 2005 Aug;21(4):275-87. doi: 10.1089/jop.2005.21.275. J Ocul Pharmacol Ther. 2005. PMID: 16117691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,387 results

Search Page